Skip to main content
Journal cover image

Clinical and angiographic efficacy of a self-expanding nitinol stent in saphenous vein graft atherosclerotic disease: the Stent Comparative Restenosis (SCORES) Saphenous Vein Graft Registry.

Publication ,  Journal Article
Kandzari, DE; Goldberg, S; Schwartz, RS; Chazin-Caldie, M; Sketch, MH; SCORES SVG Registry Investigators,
Published in: Am Heart J
May 2003

BACKGROUND: The Stent Comparative Restenosis (SCORES) Saphenous Vein Graft (SVG) Registry was a multicenter, prospective registry designed to evaluate the safety and efficacy of a self-expanding, nickel-titanium (nitinol) stent for de novo SVG lesions. METHODS: In all, 159 patients with de novo vein graft lesions > or =2.75 and < or =4.25 mm in diameter and <30 mm in length underwent stenting with the Radius self-expanding stent. The primary end point was target vessel failure (TVF) at 9 months, which was defined as a composite of procedural failure, death, myocardial infarction, or target vessel revascularization. RESULTS: Procedural success was achieved in 96.8% of patients, and the 30-day incidence of major adverse cardiac events was 2.5%. The binary rate of restenosis at 6 months was 28.6%. By 9 months, the rate of TVF was 24.5%, and the rate of major adverse cardiac events was 23.1%. The 9-month Kaplan-Meier survival rates for freedom from TVF and target lesion revascularization were 76.0% and 87.9%, respectively. No clinical or angiographic characteristic was predictive of restenosis. CONCLUSIONS: In de novo atherosclerotic SVG disease, the use of a self-expanding, nitinol stent was associated with high initial procedural success and favorable early and intermediate outcomes. Because few studies have examined the influence of stent composition and design in SVG disease, these findings not only show the safety and efficacy of this self-expanding stent in de novo SVG disease, but also merit further comparison with balloon-expandable stents.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

May 2003

Volume

145

Issue

5

Start / End Page

868 / 874

Location

United States

Related Subject Headings

  • Treatment Failure
  • Titanium
  • Survival Rate
  • Stents
  • Saphenous Vein
  • Prosthesis Design
  • Prospective Studies
  • Nickel
  • Male
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kandzari, D. E., Goldberg, S., Schwartz, R. S., Chazin-Caldie, M., Sketch, M. H., & SCORES SVG Registry Investigators, . (2003). Clinical and angiographic efficacy of a self-expanding nitinol stent in saphenous vein graft atherosclerotic disease: the Stent Comparative Restenosis (SCORES) Saphenous Vein Graft Registry. Am Heart J, 145(5), 868–874. https://doi.org/10.1016/S0002-8703(03)00020-6
Kandzari, David E., Shelley Goldberg, Robert S. Schwartz, Marilyn Chazin-Caldie, Michael H. Sketch, and Michael H. SCORES SVG Registry Investigators. “Clinical and angiographic efficacy of a self-expanding nitinol stent in saphenous vein graft atherosclerotic disease: the Stent Comparative Restenosis (SCORES) Saphenous Vein Graft Registry.Am Heart J 145, no. 5 (May 2003): 868–74. https://doi.org/10.1016/S0002-8703(03)00020-6.
Kandzari DE, Goldberg S, Schwartz RS, Chazin-Caldie M, Sketch MH, SCORES SVG Registry Investigators. Clinical and angiographic efficacy of a self-expanding nitinol stent in saphenous vein graft atherosclerotic disease: the Stent Comparative Restenosis (SCORES) Saphenous Vein Graft Registry. Am Heart J. 2003 May;145(5):868–74.
Kandzari, David E., et al. “Clinical and angiographic efficacy of a self-expanding nitinol stent in saphenous vein graft atherosclerotic disease: the Stent Comparative Restenosis (SCORES) Saphenous Vein Graft Registry.Am Heart J, vol. 145, no. 5, May 2003, pp. 868–74. Pubmed, doi:10.1016/S0002-8703(03)00020-6.
Kandzari DE, Goldberg S, Schwartz RS, Chazin-Caldie M, Sketch MH, SCORES SVG Registry Investigators. Clinical and angiographic efficacy of a self-expanding nitinol stent in saphenous vein graft atherosclerotic disease: the Stent Comparative Restenosis (SCORES) Saphenous Vein Graft Registry. Am Heart J. 2003 May;145(5):868–874.
Journal cover image

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

May 2003

Volume

145

Issue

5

Start / End Page

868 / 874

Location

United States

Related Subject Headings

  • Treatment Failure
  • Titanium
  • Survival Rate
  • Stents
  • Saphenous Vein
  • Prosthesis Design
  • Prospective Studies
  • Nickel
  • Male
  • Humans